Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Begier

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|November 6, 2023
Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort StudyEero Poukka, Caren van Roekel, Topi Turunen, et al.
Journal of Public Health Management and Practice : JPHMP|March 2, 2013
Evaluation of a pilot respiratory virus surveillance system linking electronic health record and diagnostic dataTeeb Al-Samarrai, Winfred Wu, Elizabeth Begier, et al.
Human Vaccines & Immunotherapeutics|March 9, 2026
A narrative review of considerations when assessing potential relationships between Guillain-Barré syndrome and vaccinesSarah Elizabeth Williams, Olympia Evdoxia Anastasiou, Maria Maddalena Lino, et al.
Journal of Epidemiology and Global Health|January 9, 2026
Estimated Incidence of All-Cause Respiratory Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Finland between 2011 and 2019: A Retrospective Database StudyRobin Bruyndonckx, Aleksandra Polkowska-Kramek, Caihua Liang, et al.
The Journal of Infectious Diseases|November 7, 2023
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control StudyCaren van Roekel, Eero Poukka, Topi Turunen, et al.
Influenza and Other Respiratory Viruses|April 20, 2025
Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Australia Between 2010 and 2019Zirke Wiid, Caihua Liang, Robin Bruyndonckx, et al.
Vaccine|February 2, 2017
SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodiesElizabeth Begier, David Joshua Seiden, Michael Patton, et al.
Open Forum Infectious Diseases|June 22, 2026
Hospitalization Burden Estimates of Respiratory Syncytial Virus With Adjustment for Case Underascertainment in Adults Aged 18 to 65 Years in High-Income Countries: A Systematic Review, Meta-Analysis, and Modeling StudyYou Li, Sebastien Kenmoe, Elizabeth Begier, et al.
AIDS (London, England)|December 22, 2007
Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004Trang Quyen Nguyen, R Charon Gwynn, Scott E Kellerman, et al.
Journal of Epidemiology and Global Health|August 14, 2025
Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Norway between 2010 and 2019: A Time-Series Modelling StudyMaribel Casas, Caihua Liang, Tor Molden, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|November 6, 2023
Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort StudyEero Poukka, Caren van Roekel, Topi Turunen, et al.
Journal of Public Health Management and Practice : JPHMP|March 2, 2013
Evaluation of a pilot respiratory virus surveillance system linking electronic health record and diagnostic dataTeeb Al-Samarrai, Winfred Wu, Elizabeth Begier, et al.
Human Vaccines & Immunotherapeutics|March 9, 2026
A narrative review of considerations when assessing potential relationships between Guillain-Barré syndrome and vaccinesSarah Elizabeth Williams, Olympia Evdoxia Anastasiou, Maria Maddalena Lino, et al.
Journal of Epidemiology and Global Health|January 9, 2026
Estimated Incidence of All-Cause Respiratory Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Finland between 2011 and 2019: A Retrospective Database StudyRobin Bruyndonckx, Aleksandra Polkowska-Kramek, Caihua Liang, et al.
The Journal of Infectious Diseases|November 7, 2023
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control StudyCaren van Roekel, Eero Poukka, Topi Turunen, et al.
Influenza and Other Respiratory Viruses|April 20, 2025
Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Australia Between 2010 and 2019Zirke Wiid, Caihua Liang, Robin Bruyndonckx, et al.
Vaccine|February 2, 2017
SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodiesElizabeth Begier, David Joshua Seiden, Michael Patton, et al.
Open Forum Infectious Diseases|June 22, 2026
Hospitalization Burden Estimates of Respiratory Syncytial Virus With Adjustment for Case Underascertainment in Adults Aged 18 to 65 Years in High-Income Countries: A Systematic Review, Meta-Analysis, and Modeling StudyYou Li, Sebastien Kenmoe, Elizabeth Begier, et al.
AIDS (London, England)|December 22, 2007
Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004Trang Quyen Nguyen, R Charon Gwynn, Scott E Kellerman, et al.
Journal of Epidemiology and Global Health|August 14, 2025
Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Norway between 2010 and 2019: A Time-Series Modelling StudyMaribel Casas, Caihua Liang, Tor Molden, et al.
Pageof 14